Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.
2.

The pathology of T cells in systemic lupus erythematosus.

Mak A, Kow NY.

J Immunol Res. 2014;2014:419029. doi: 10.1155/2014/419029. Epub 2014 Apr 23. Review.

3.

Pathogenesis of renal disease in systemic lupus erythematosus--the role of autoantibodies and lymphocytes subset abnormalities.

Yap DY, Lai KN.

Int J Mol Sci. 2015 Apr 9;16(4):7917-31. doi: 10.3390/ijms16047917. Review.

4.

CD3 antibody treatment stimulates the functional capability of regulatory T cells.

Chatenoud L.

Novartis Found Symp. 2003;252:279-86; discussion 286-90. Review.

PMID:
14609225
5.

Cellular and molecular mechanisms of regulation of autoantibody production in lupus.

Hahn BH, Ebling F, Singh RR, Singh RP, Karpouzas G, La Cava A.

Ann N Y Acad Sci. 2005 Jun;1051:433-41. Review.

6.

[The significance of regulatory CD4+CD25+ T cells in the pathogenesis and treatment of kidney disease].

Krajewska M, Weyde W, Klinger M.

Postepy Hig Med Dosw (Online). 2007;61:178-84. Review. Polish.

7.

T follicular helper cells, interleukin-21 and systemic lupus erythematosus.

Gensous N, Schmitt N, Richez C, Ueno H, Blanco P.

Rheumatology (Oxford). 2017 Apr 1;56(4):516-523. doi: 10.1093/rheumatology/kew297. Review.

PMID:
27498357
8.

Follicular Helper T Cells in Systemic Lupus Erythematosus: Why Should They Be Considered as Interesting Therapeutic Targets?

Sawaf M, Dumortier H, Monneaux F.

J Immunol Res. 2016;2016:5767106. doi: 10.1155/2016/5767106. Epub 2016 Aug 22. Review.

9.
10.

Systemic lupus erythematosus in the light of the regulatory effects of galectin-1 on T-cell function.

Hornung Á, Monostori É, Kovács L.

Lupus. 2017 Apr;26(4):339-347. doi: 10.1177/0961203316686846. Epub 2017 Jan 18. Review.

PMID:
28100106
11.

New immunosuppressive approaches: oral administration of CD3-specific antibody to treat autoimmunity.

Ochi H, Abraham M, Ishikawa H, Frenkel D, Yang K, Basso A, Wu H, Chen ML, Gandhi R, Miller A, Maron R, Weiner HL.

J Neurol Sci. 2008 Nov 15;274(1-2):9-12. doi: 10.1016/j.jns.2008.07.027. Epub 2008 Sep 18. Review.

12.

Follicular T helper cells and IL-21 in rheumatic diseases.

Rasmussen TK.

Dan Med J. 2016 Oct;63(10). pii: B5297. Review.

PMID:
27697141
13.

[Tc1-mediated contact sensitivity reaction, its mechanism and regulation].

Zemelka-Wiącek M, Szczepanik M.

Postepy Hig Med Dosw (Online). 2014 Jul 4;68:955-69. Review. Polish.

14.

Immunoregulation of NKT Cells in Systemic Lupus Erythematosus.

Chen J, Wu M, Wang J, Li X.

J Immunol Res. 2015;2015:206731. doi: 10.1155/2015/206731. Epub 2015 Dec 24. Review.

15.

Immunometabolism in systemic lupus erythematosus.

Morel L.

Nat Rev Rheumatol. 2017 May;13(5):280-290. doi: 10.1038/nrrheum.2017.43. Epub 2017 Mar 31. Review.

PMID:
28360423
16.
17.

Low-Dose IL-2 in the Treatment of Lupus.

Mizui M, Tsokos GC.

Curr Rheumatol Rep. 2016 Nov;18(11):68. Review.

PMID:
27734211
18.

Posttranscriptional T cell gene regulation to limit Tfh cells and autoimmunity.

Jiang SH, Shen N, Vinuesa CG.

Curr Opin Immunol. 2015 Dec;37:21-7. doi: 10.1016/j.coi.2015.09.003. Epub 2015 Sep 30. Review.

PMID:
26432764
19.

[Mechanism of glomerular lesions in lupus erythematosus disseminatus].

Tron F.

Presse Med. 1987 Apr 4;16(12):583-5. Review. French.

PMID:
2952955
20.

Induction of mucosal tolerance in SLE: a sniff or a sip away from ameliorating lupus?

Wu HY.

Clin Immunol. 2009 Feb;130(2):111-22. doi: 10.1016/j.clim.2008.08.028. Epub 2008 Oct 19. Review.

Supplemental Content

Support Center